DBV DBVT Stock
DBV Price Chart
DBV DBVT Financial and Trading Overview
| DBV stock price | 6.5 USD |
| Previous Close | 1.92 USD |
| Open | 1.91 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 1000 |
| Day's Range | 1.89 - 1.93 USD |
| 52 Week Range | 1.08 - 2.94 USD |
| Volume | 53.61K USD |
| Avg. Volume | 137.8K USD |
| Market Cap | 362.8M USD |
| Beta (5Y Monthly) | 1.184291 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.85 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.18 USD |
DBVT Valuation Measures
| Enterprise Value | 171.23M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.244186 |
| PEG Ratio (5 yr expected) | -0.1 |
| Price/Sales (ttm) | 80.76569 |
| Price/Book (mrq) | 2.0262468 |
| Enterprise Value/Revenue | 38.12 |
| Enterprise Value/EBITDA | -1.976 |
Trading Information
DBV Stock Price History
| Beta (5Y Monthly) | 1.184291 |
| 52-Week Change | -14.22% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.94 USD |
| 52 Week Low | 1.08 USD |
| 50-Day Moving Average | 1.77 USD |
| 200-Day Moving Average | 1.62 USD |
DBVT Share Statistics
| Avg. Volume (3 month) | 137.8K USD |
| Avg. Daily Volume (10-Days) | 455.41K USD |
| Shares Outstanding | 187.98M |
| Float | 62.72M |
| Short Ratio | 11.71 |
| % Held by Insiders | 0.19% |
| % Held by Institutions | 28.21% |
| Shares Short | 1.69M |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.89% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -2249.019% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -36.027% |
| Return on Equity (ttm) | -76.68% |
Income Statement
| Revenue (ttm) | 4.49M USD |
| Revenue Per Share (ttm) | 0.03 USD |
| Quarterly Revenue Growth (yoy) | -13.80% |
| Gross Profit (ttm) | 4.84M USD |
| EBITDA | -86667504 USD |
| Net Income Avi to Common (ttm) | -100129000 USD |
| Diluted EPS (ttm) | -0.6 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 192.29M USD |
| Total Cash Per Share (mrq) | 1.02 USD |
| Total Debt (mrq) | 2.6M USD |
| Total Debt/Equity (mrq) | 1.45 USD |
| Current Ratio (mrq) | 6.414 |
| Book Value Per Share (mrq) | 0.9525 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -75024000 USD |
| Levered Free Cash Flow (ttm) | -39472248 USD |
Profile of DBV
| Country | United States |
| State | N/A |
| City | Montrouge |
| Address | 177-181 Avenue Pierre Brossolette |
| ZIP | 92120 |
| Phone | 33 1 55 42 78 78 |
| Website | https://www.dbv-technologies.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 88 |
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies. The company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA) and eosinophilic esophagitis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn's disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Montrouge, France.
Q&A For DBV Stock
What is a current DBVT stock price?
DBV DBVT stock price today per share is 6.5 USD.
How to purchase DBV stock?
You can buy DBVT shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for DBV?
The stock symbol or ticker of DBV is DBVT.
Which industry does the DBV company belong to?
The DBV industry is Biotechnology.
How many shares does DBV have in circulation?
The max supply of DBV shares is 23.41M.
What is DBV Price to Earnings Ratio (PE Ratio)?
DBV PE Ratio is now.
What was DBV earnings per share over the trailing 12 months (TTM)?
DBV EPS is -5.85 USD over the trailing 12 months.
Which sector does the DBV company belong to?
The DBV sector is Healthcare.
DBV DBVT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15587.79 USD — |
-5.82
|
9.14B USD — | 15575.68 USD — | 16128.16 USD — | — - | 9.14B USD — |
| NASDAQ Composite Total Return I XCMP | 19079.55 USD — |
-5.82
|
— — | 19064.73 USD — | 19740.96 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4224.19 USD — |
-5.49
|
— — | 4221.36 USD — | 4397.83 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7625.89 USD — |
-5.84
|
— — | 7621.56 USD — | 7894.21 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 869.8 USD — |
-5.51
|
— — | 868.74 USD — | 900.72 USD — | — - | — — |
- {{ link.label }} {{link}}